ALSO NOTED: Membership up at Aetna, PacifiCare up; BMS may withdraw Pargluva; and much more...

> Membership grows at Aetna and PacifiCare, which both reported reasonably positive third-quarter results Thursday. Article [1] 

> Following an article in JAMA criticizing the methodology used in submitting
data to the FDA, Bristol-Myers Squibb may withdraw Pargluva. Article [2] 

> Cancer therapy systems specialist Varian reports earnings up 23 percent to $207 million. Release [3]

> In California, drug makers have spent more than $75 million to support Prop. 78 and oppose Prop.79. Article [4]

> The Department of Health and Human Services awarded Chiron a contract to develop an experimental H5N1 vaccine. Article [5] 

> eICU company VISICU announced its latest deal in a string of successes, signing Via Christi Health System of Wichita to use its remote ICU monitoring system. Release [6]

> Siemens Medical Systems scores a Soarian implementation with Singapore's National Health System. Release [7]

> Connectologist Tim Gee reports from the Urgent Matters Perfecting Patient Flow conference in Las Vegas. Blog [8] 

> iMedica debuted its new patient relationship management system at this week's MGMA Conference in Nashville. Release [9]

And Finally... Controversy over the future of patient medical records in New Zealand. Article [10]